Cargando…

Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB

The nuclear receptor REV-ERB plays an important role in a range of physiological processes. REV-ERB behaves as a ligand-dependent transcriptional repressor and heme has been identified as a physiological agonist. Our current understanding of how ligands bind to and regulate transcriptional repressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Meghan H., Valfort, Aurore Cecile, Koelblen, Thomas, Ronin, Céline, Ciesielski, Fabrice, Chatterjee, Arindam, Veerakanellore, Giri Babu, Elgendy, Bahaa, Walker, John K., Hegazy, Lamees, Burris, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681850/
https://www.ncbi.nlm.nih.gov/pubmed/36414641
http://dx.doi.org/10.1038/s41467-022-34892-4
_version_ 1784834718098784256
author Murray, Meghan H.
Valfort, Aurore Cecile
Koelblen, Thomas
Ronin, Céline
Ciesielski, Fabrice
Chatterjee, Arindam
Veerakanellore, Giri Babu
Elgendy, Bahaa
Walker, John K.
Hegazy, Lamees
Burris, Thomas P.
author_facet Murray, Meghan H.
Valfort, Aurore Cecile
Koelblen, Thomas
Ronin, Céline
Ciesielski, Fabrice
Chatterjee, Arindam
Veerakanellore, Giri Babu
Elgendy, Bahaa
Walker, John K.
Hegazy, Lamees
Burris, Thomas P.
author_sort Murray, Meghan H.
collection PubMed
description The nuclear receptor REV-ERB plays an important role in a range of physiological processes. REV-ERB behaves as a ligand-dependent transcriptional repressor and heme has been identified as a physiological agonist. Our current understanding of how ligands bind to and regulate transcriptional repression by REV-ERB is based on the structure of heme bound to REV-ERB. However, porphyrin (heme) analogues have been avoided as a source of synthetic agonists due to the wide range of heme binding proteins and potential pleotropic effects. How non-porphyrin synthetic agonists bind to and regulate REV-ERB has not yet been defined. Here, we characterize a high affinity synthetic REV-ERB agonist, STL1267, and describe its mechanism of binding to REV-ERB as well as the method by which it recruits transcriptional corepressor both of which are unique and distinct from that of heme-bound REV-ERB.
format Online
Article
Text
id pubmed-9681850
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96818502022-11-24 Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB Murray, Meghan H. Valfort, Aurore Cecile Koelblen, Thomas Ronin, Céline Ciesielski, Fabrice Chatterjee, Arindam Veerakanellore, Giri Babu Elgendy, Bahaa Walker, John K. Hegazy, Lamees Burris, Thomas P. Nat Commun Article The nuclear receptor REV-ERB plays an important role in a range of physiological processes. REV-ERB behaves as a ligand-dependent transcriptional repressor and heme has been identified as a physiological agonist. Our current understanding of how ligands bind to and regulate transcriptional repression by REV-ERB is based on the structure of heme bound to REV-ERB. However, porphyrin (heme) analogues have been avoided as a source of synthetic agonists due to the wide range of heme binding proteins and potential pleotropic effects. How non-porphyrin synthetic agonists bind to and regulate REV-ERB has not yet been defined. Here, we characterize a high affinity synthetic REV-ERB agonist, STL1267, and describe its mechanism of binding to REV-ERB as well as the method by which it recruits transcriptional corepressor both of which are unique and distinct from that of heme-bound REV-ERB. Nature Publishing Group UK 2022-11-21 /pmc/articles/PMC9681850/ /pubmed/36414641 http://dx.doi.org/10.1038/s41467-022-34892-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Murray, Meghan H.
Valfort, Aurore Cecile
Koelblen, Thomas
Ronin, Céline
Ciesielski, Fabrice
Chatterjee, Arindam
Veerakanellore, Giri Babu
Elgendy, Bahaa
Walker, John K.
Hegazy, Lamees
Burris, Thomas P.
Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title_full Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title_fullStr Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title_full_unstemmed Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title_short Structural basis of synthetic agonist activation of the nuclear receptor REV-ERB
title_sort structural basis of synthetic agonist activation of the nuclear receptor rev-erb
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681850/
https://www.ncbi.nlm.nih.gov/pubmed/36414641
http://dx.doi.org/10.1038/s41467-022-34892-4
work_keys_str_mv AT murraymeghanh structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT valfortaurorececile structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT koelblenthomas structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT roninceline structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT ciesielskifabrice structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT chatterjeearindam structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT veerakanelloregiribabu structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT elgendybahaa structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT walkerjohnk structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT hegazylamees structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb
AT burristhomasp structuralbasisofsyntheticagonistactivationofthenuclearreceptorreverb